Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-13-025706
Filing Date
2013-05-13
Accepted
2013-05-13 09:50:35
Documents
1
Period of Report
2013-05-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4769
  Complete submission text file 0001209191-13-025706.txt   6262
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Issuer) CIK: 0000786947 (see all company filings)

EIN.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ACURA PHARMACEUTICALS, INC. 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067
Business Address
SKELLY WILLIAM G (Reporting) CIK: 0001058352 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-10113 | Film No.: 13835577